Upgrade to SI Premium - Free Trial

Form EFFECT GALECTIN THERAPEUTICS

April 13, 2026 6:04 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 10, 2026 4:00 P.M.
Form: S-3
CIK: 0001133416
Company Name: GALECTIN THERAPEUTICS INC
File Number: 333-294782

Categories

SEC Filings